Best Shipping Stocks To Own For 2016

Best Shipping Stocks To Own For 2016: Celldex Therapeutics Inc(CLDX)

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. The company markets Rotarix to treat rotavirus infection. Its lead drug candidate, rindopepimut (CDX-110), is an immunotherapeutic vaccine in Phase III clinical trial to target the tumor-specific molecule, epidermal growth factor receptor variant III, as well as in Phase II clinical trial for the indication of recurrent glioblastoma. The company?s other lead drug candidates comprise CDX-011, an antibody-drug conjugate in Phase IIb clinical trial for metastatic breast cancer and melanoma indication; and CDX-1127, a human monoclonal antibody in Phase I clinical trial for the treatment of lymphoma/leukemia and solid tumors. Its additional clinical and preclinical programs consist of CDX-1401, an Antigen Presenting Cells Targeting Technology program in Phase I/II clinical trial to tr eat multiple solid tumors; and CDX-301, an immune cell mobilizing agent and dendritic cell growth factor in Phase I clinical for treating cancer, autoimmune disease, and transplant. The company?s preclinical products include CDX-1135, a molecule for treating renal disease; and CDX-014, a human monoclonal antibody-drug conjugate for the treatment of ovarian and renal cancer. It has research collaboration and license agreements with Medarex, Inc.; Rockefeller University; Duke University Brain Tumor Cancer Center; Ludwig Institute for Cancer Research; Alteris Therapeutics, Inc.; Thomas Jefferson University; 3M Company; University of Southampton; Amgen Inc.; Amgen Fremont; and Seattle Genetics, Inc. Celldex Therapeutics, Inc. was founded in 1983 and is headquartered in Needham, Massachusetts.

Advisors' Opinion:

• [By Luke Jacobi]

  Celldex Therapeutics (NASDAQ: CLDX) gained 12.91 percent to $32.70 after a bullish report out o! f Leerink Swann.

  Shares of Pandora (NYSE: P) lost 10.11 percent to $24.26 as traders looked to take profit on the stock after shares posted a massive rally over the past 3 weeks.

• [By Bryan Murphy]

  A week ago, yours truly recommended adding EnteroMedics Inc. (NASDAQ:ETRM), Arrowhead Research Corp. (NASDAQ:ARWR), and Celldex Therapeutics, Inc. (NASDAQ:CLDX) to your watchlist, all as bullish candidates. Although ETRM was a bust, CLDX and ARWR are both still compelling. In fact, those two survivors merit an updated look, as each has moved further along its bullish path, and each looks like it's itching to put the pedal to the metal.

• [By Harry Boxer]

  HARRY:  There are an awful lot of stocks that I’ve recommended this year that have done great, but a lot of them had big runs.  The stock I like now is Celldex (CLDX); another one is ACAD.

• [By Ben Levisohn]

  Acorda has dropped 6.3% to $33.12 today at 2pm, while MannKind has gained 5.1% to $5.37. Vertexs Pharmaceuticals (VRTX) has gained 3.3% to $73.25, Celldex Therapeutics (CLDX) has jumped 2.4% to $27.86 and Gilead Sciences (GILD) has ticked up 0.8% to $63.18.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/best-shipping-stocks-to-own-for-2016.html